ZoBio

ZoBio is a leading innovator that provides gene to structure research services in early stage drug discovery. The company is a privately held, self-funded and founded in 2004. We are specialized in 4 areas: 1) enabling proteins for biophysical and structural biology studies, 2) using biophysics to screen fragment libraries for selective ligands for a pharmaceutical target, 3) using both X-ray crystallography and NMR to provide 3D structural information on complexes of ligands bound to a protein and 4) using medicinal chemistry expertise to advance fragment hits. 1) Every protein ZoBio produces is crystallography quality. For structurally unprecedented, challenging proteins,...

Protein production,fragment library screening,structural biology,nuclear magnetic resonance,x-ray crystallography,medchem for fragment elaboration,and high throughput protein engineering

Zobio operates in the Biotechnology industry.

Zobio's revenue is 11m - 100m

Zobio has 11 - 50 employees.